You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

Immunisation and global solidarity

By Dermot - 05th May 2021 | 16 views

Vaccines have dominated the news agenda recently for obvious reasons. But it can be easy to forget that Covid-19 is not the only threat to global health and that many other diseases require essential vaccination programmes to be kept under control. Nevertheless, the current pandemic has made it difficult for these programmes – which vaccinate against life-threatening diseases like measles, yellow fever, and diphtheria – to stay fully operational.

While immunisation services have begun to recover from disruptions caused by Covid-19, millions of children remain vulnerable to deadly diseases, according to the World Health Organisation (WHO), UNICEF, and Gavi, the Vaccine Alliance. During World Immunisation Week, which took place between 24-30 April, the organisations highlighted the urgent need for a renewed global commitment to improve vaccination access and uptake.

A WHO survey has found that, despite progress when compared to the situation in 2020, more than one-third of respondent countries (37 per cent) still report experiencing disruptions to their routine immunisation services.
Mass immunisation campaigns are also disrupted. According to new data, 60 of these lifesaving campaigns are currently postponed in 50 countries. This is putting around 228 million people, mostly children, at risk.

Over half of the 50 affected countries are in Africa, which highlights protracted inequities in access to these critical immunisation services. Measles campaigns account for 23 of the postponed campaigns, affecting an estimated 140 million people. As a result of gaps in vaccination coverage, serious measles outbreaks have recently been reported in countries including the Democratic Republic of the Congo, Pakistan, and Yemen.

The supply of vaccines and other equipment is also essential for child vaccinations. Due to disruptions at the onset of the Covid-19 pandemic, UNICEF delivered 2.01 billion vaccine doses in 2020, compared to 2.29 billion in 2019.
In response to this worrying situation, WHO, UNICEF, Gavi, and other partners have launched the Immunisation Agenda 2030 (IA2030), a new global strategy to build stronger immunisation systems.

Among the strategy’s calls is for the pharmaceutical industry and scientists, working with governments and funders, to continue to accelerate vaccine development, ensure a continuous supply of affordable vaccines to meet global needs and “apply lessons from Covid-19 to other diseases”.

But Covid-19 is shining a new light on how vaccination development, pricing, and indeed purchasing, is often far from equitable.

Recent data from Duke University’s Global Health Innovation Centre show high-income countries currently hold a confirmed 4.7 billion doses of Covid-19 vaccines and, upper middle-income countries hold 1.5 billion. This compares to lower middle-income countries, which hold 732 million doses, and low-income countries, which hold 770 million. Many high-income countries have also advance purchasing of enough doses to vaccinate their population several times over.
Current models predict there will not be enough vaccines to cover the world’s population until 2023 or 2024.

In this context, initiatives such as the COVAX alliance are critical to ensuring equitable allocation of vaccines internationally. It is also essential that the pharmaceutical industry does not price lower income countries out of the market. Without global solidarity, the threat of Covid-19, and its knock-on impact on other vital health services, will continue for years to come.

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]